Arcadia Biosciences, Inc

(NASDAQ:RKDA)

Latest On Arcadia Biosciences, Inc (RKDA):

Date/Time Type Description Signal Details
2023-05-12 00:11 ESTNewsArcadia Biosciences reports Q1 resultsN/A
2023-05-12 00:11 ESTNewsArcadia Biosciences, Inc. (RKDA) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 20:02 ESTNewsArcadia Biosciences Q1 Earnings PreviewN/A
2023-04-04 02:31 ESTNewsArcadia Biosciences announces secondary offering of over 2M common stockN/A
2023-03-31 09:47 ESTNewsArcadia Biosciences, Inc. (RKDA) Q4 2022 Financial Results TranscriptN/A
2023-03-31 09:47 ESTNewsArcadia Biosciences GAAP EPS of -$6.31 beats by $0.49, revenue of $1M misses by $1MN/A
2023-03-29 17:42 ESTNewsArcadia Biosciences Q4 Earnings PreviewN/A
2023-03-03 11:20 ESTNewsArcadia Biosciences to raise $6M in stock offeringN/A
2022-12-08 13:12 ESTNewsArcadia Biosciences doubles retail footprint for its GoodWheat pasta brandN/A
2022-11-10 22:36 ESTNewsArcadia Biosciences GAAP EPS of -$0.12 beats by $0.09, revenue of $1.87M misses by $0.8MN/A
2022-11-10 22:36 ESTNewsArcadia Biosciences Inc (RKDA) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 05:12 ESTNewsArcadia Biosciences Q3 2022 Earnings PreviewN/A
2022-08-15 03:50 ESTNewsArcadia Biosciences to raise $5M in securities offeringN/A
2022-08-12 07:19 ESTNewsArcadia Biosciences GAAP EPS of -$0.17 beats by $0.12, revenue of $3.86M beats by $1.56MN/A
2022-08-12 07:18 ESTNewsArcadia Biosciences Inc (RKDA) CEO Stan Jacot on Q2 2022 Results - Earnings Call TranscriptN/A
2022-05-13 00:13 ESTNewsArcadia Biosciences GAAP EPS of -$0.20 beats by $0.14, revenue of $3.22M beats by $1.32MN/A
2022-05-13 00:13 ESTNewsArcadia Biosciences, Inc. (RKDA) CEO Stan Jacot on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 04:13 ESTNewsArcadia Biosciences Q1 2022 Earnings PreviewN/A
2022-04-22 00:24 ESTNewsArcadia Biosciences drops 4% on $50M mixed shelf offeringN/A
2022-03-31 17:03 ESTNewsArcadia Biosciences stock sees 25% wipeout as Q4 revenue falls ~70% Y/YN/A
2022-03-30 23:19 ESTNewsArcadia Biosciences GAAP EPS of -$0.42 misses by $0.12, revenue of $2.17M misses by $1.16MN/A
2022-03-30 23:19 ESTNewsArcadia Biosciences, Inc. (RKDA) CEO Stan Jacot on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-30 06:36 ESTNewsArcadia Biosciences Q4 2021 Earnings PreviewN/A
2022-02-03 00:04 ESTNewsArcadia Biosciences appoints CEON/A
2022-01-04 01:53 ESTNewsArcadia Biosciences defended at H.C. Wainwright after CEO departureN/A
2021-12-20 13:39 ESTNewsArcadia Biosciences names an interim CEON/A
2021-11-30 10:44 ESTNewsArcadia Biosciences - An UpdateN/A
2021-11-29 14:04 ESTNewsArcadia Biosciences: Market Still Unconvinced Of Its Health OfferingsN/A
2021-11-16 07:04 ESTNewsArcadia Biosciences EPS beats by $0.26, misses on revenueN/A
2021-11-16 07:04 ESTNewsArcadia Biosciences' (RKDA) CEO Matt Plavan on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-15 11:48 ESTNewsArcadia Biosciences Q3 2021 Earnings PreviewN/A
2021-09-22 05:02 ESTNewsArcadia Biosciences (RKDA) Investor Presentation - SlideshowN/A
2021-09-07 19:35 ESTNewsArcadia Biosciences CEO Matt Plavan stepping downN/A
2021-08-17 00:02 ESTNewsArcadia Biosciences EPS beats by $0.03, misses on revenueN/A
2021-08-17 00:02 ESTNewsArcadia Biosciences' (RKDA) CEO Matt Plavan on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-15 09:57 ESTNewsArcadia Biosciences Q2 2021 Earnings PreviewN/A
2021-07-21 22:44 ESTNewsArcadia Biosciences:  Vertical Integration To Drive Growth And ProfitabilityN/A
2021-03-31 07:28 ESTNewsArcadia Biosciences EPS beats by $1.31, beats on revenueN/A
2021-03-31 07:28 ESTNewsArcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-18 13:29 ESTAnalyst RatingThe Analyst Target Price has increased from $6.52 to $7.53.Buy
2021-03-13 06:39 ESTNewsArcadia Biosciences (RKDA) Presents At Global Life Sciences Virtual Conference - SlideshowN/A
2021-02-17 12:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.83 to $6.52.Neutral
2021-02-10 12:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.5 to $6.83.Neutral
2021-01-27 12:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $8.67 to $7.5.Neutral
2021-01-25 21:43 ESTNewsArcadia Biosciences plunges on $25.1M private placementN/A
2020-12-29 12:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.33 to $8.67.Neutral
2020-12-22 12:39 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.67 to $9.33.Neutral
2020-12-18 17:36 ESTNewsArcadia Biosciences launches $8M direct equity offering, stock -18%N/A
2020-12-02 02:47 ESTNewsThe Future Looks Bright For Arcadia BiosciencesN/A
2020-12-01 12:56 ESTAnalyst RatingThe Analyst Target Price has decreased from $11.33 to $10.67.Neutral

About Arcadia Biosciences, Inc (RKDA):

Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.

RKDA Quotes by TradingView

See Advanced Chart

General

  • Name Arcadia Biosciences, Inc
  • Symbol RKDA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • Full Time Employees 41
  • Last Split Factor1:20
  • Last Split Date2018-01-24
  • Fiscal Year EndDecember
  • IPO Date2015-05-15
  • Gic SectorConsumer Staples
  • Gic GroupFood, Beverage & Tobacco
  • Gic IndustryFood Products
  • Gic SubIndustryAgricultural Products
  • Web URLhttp://www.arcadiabio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 22.44
  • Price/Book (Most Recent Quarter) 5.99
  • Enterprise Value Revenue 50.71
  • Enterprise Value EBITDA 0.07
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.44
  • Operating Margin -1687%
  • Return on Assets -39%
  • Return on Equity -160%
  • Revenue 1.32 million
  • Earnings Per Share -$0.94
  • Revenue Per Share $0.14
  • Gross Profit -6814000
  • Quarterly Earnings Growth -19.9%
View More

Highlights

  • Market Capitalization 66.76 million
  • EBITDA -17520000
  • PE Ratio -0.19
  • PEG Ratio -0.08
  • Analyst Target Price $7.53
  • Book Value Per Share $1.04
View More

Share Statistics

  • Shares Outstanding 21.33 million
  • Shares Float 10.23 million
  • % Held by Insiders 1219%
  • % Held by Institutions 11.17%
  • Shares Short 993104
  • Shares Short Prior Month 2.83 million
  • Short Ratio 0.31
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta -0.7
  • 52 Week High $6.4
  • 52 Week Low $2.3
  • 50 Day Moving Average 3.28
  • 200 Day Moving Average 3.07
View More

Dividends

  • Dividend Date 2018-01-24
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Arcadia Biosciences, Inc (RKDA) Dividend Calendar:

RKDA's last dividend payment was made to shareholders on January 24, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Arcadia Biosciences, Inc (RKDA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$N/A-$0.60-$0.54-10.44%
2020-06-302020-08-13$N/A-$1.04-$0.59-77.26%
2020-03-312020-05-13$309000$0.29-$0.55153.21%
2019-12-312020-03-25$416000-$0.50-$0.5813.04%
2019-09-302019-11-06$392000-$2.04-$0.77-164.94%
2019-06-302019-08-14$203000$0.84-$0.91192.82%
2019-03-312019-05-08$158000-$2.64-$1.01-161.39%
2018-12-312019-03-27$444000-$0.14-$0.7681.58%
2018-09-302018-11-07$370000$0.93-$1.13182.3%
2018-06-302018-08-08$436000-$2.02-$1.29-56.59%
2018-03-312018-05-09$214000-$4.86-$1.60-203.75%
2017-12-312018-03-20$1.43 million-$1.39-$2.0030.65%
2017-09-302017-11-09$589000-$2.20-$1.60-37.5%
2017-06-302017-08-10$991000-$1.80-$2.2018.18%
2017-03-312017-05-10$1.02 million-$2.00-$1.40-42.86%
2016-12-312017-03-08$540000-$2.60-$2.00-30%
2016-09-302016-11-10$1.08 million-$1.80-$1.40-28.57%
2016-06-302016-08-09$721000-$2.00-$1.40-42.86%
2016-03-312016-05-10$852000-$2.40-$1.40-71.43%
2015-12-312016-03-08$1.35 million-$1.80-$1.40-28.57%
2015-09-302015-11-05$1.82 million-$0.11-$0.07-57.14%
2015-06-302015-08-10$1.43 million-$0.19-$0.11-72.73%
2015-03-312015-05-15$815000-$3.71-$0.11-3272.73%

Arcadia Biosciences, Inc (RKDA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Arcadia Biosciences, Inc (RKDA) Chart:

Arcadia Biosciences, Inc (RKDA) News:

Below you will find a list of latest news for Arcadia Biosciences, Inc (RKDA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Arcadia Biosciences, Inc (RKDA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest RKDA Trades:

Date Shares Price
Jun 13, 2022 7:32 PM EST662$1.165
Jun 13, 2022 7:42 PM EST500$1.155
Jun 13, 2022 7:42 PM EST500$1.155
Jun 13, 2022 7:55 PM EST100$1.11
Jun 13, 2022 7:59 PM EST40$1.095

Arcadia Biosciences, Inc (RKDA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000156459020031637/0001564590-20-031637-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1469443/000000000019001509/0000000000-19-001509-index.htm
2019-08-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1469443/000000000019012130/0000000000-19-012130-index.htm
2019-12-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1469443/000000000019016499/0000000000-19-016499-index.htm
2020-07-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1469443/000000000020006130/0000000000-20-006130-index.htm
2019-09-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000091957419005894/0000919574-19-005894-index.htm
2018-06-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000110465918041510/0001104659-18-041510-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000110465919008592/0001104659-19-008592-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000110465920021843/0001104659-20-021843-index.htm
2019-09-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000114420419043927/0001144204-19-043927-index.htm
2018-06-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1469443/000119312518191772/0001193125-18-191772-index.htm
2018-12-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000119312518359270/0001193125-18-359270-index.htm
2019-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1469443/000119312519038119/0001193125-19-038119-index.htm
2019-06-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1469443/000119312519173160/0001193125-19-173160-index.htm
2019-07-26S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000119312519204064/0001193125-19-204064-index.htm
2019-08-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000119312519225557/0001193125-19-225557-index.htm
2019-08-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1469443/000119312519225559/0001193125-19-225559-index.htm
2019-08-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1469443/000119312519229360/0001193125-19-229360-index.htm
2019-08-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1469443/000119312519231252/0001193125-19-231252-index.htm
2019-09-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1469443/000119312519241094/0001193125-19-241094-index.htm
2019-09-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000119312519242789/0001193125-19-242789-index.htm
2019-12-11S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000119312519310417/0001193125-19-310417-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000119312520038344/0001193125-20-038344-index.htm
2018-06-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036757/0001209191-18-036757-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036791/0001209191-18-036791-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036792/0001209191-18-036792-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036795/0001209191-18-036795-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036801/0001209191-18-036801-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036805/0001209191-18-036805-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118036806/0001209191-18-036806-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118051839/0001209191-18-051839-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118051840/0001209191-18-051840-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919118051841/0001209191-18-051841-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119034578/0001209191-19-034578-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119034580/0001209191-19-034580-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119034583/0001209191-19-034583-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119034585/0001209191-19-034585-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119034596/0001209191-19-034596-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119034598/0001209191-19-034598-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119035492/0001209191-19-035492-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119035500/0001209191-19-035500-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119035510/0001209191-19-035510-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-08-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/0001209191-19-047582-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119049067/0001209191-19-049067-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119049070/0001209191-19-049070-index.htm
2019-09-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119049071/0001209191-19-049071-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/0001209191-19-049077-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119049954/0001209191-19-049954-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119050493/0001209191-19-050493-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119056884/0001209191-19-056884-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119057084/0001209191-19-057084-index.htm
2019-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119057375/0001209191-19-057375-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919119061814/0001209191-19-061814-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120006282/0001209191-20-006282-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120006290/0001209191-20-006290-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120006294/0001209191-20-006294-index.htm
2020-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120023342/0001209191-20-023342-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120023345/0001209191-20-023345-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120033824/0001209191-20-033824-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120033825/0001209191-20-033825-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120033826/0001209191-20-033826-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120033827/0001209191-20-033827-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120033828/0001209191-20-033828-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120042124/0001209191-20-042124-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1469443/000120919120042125/0001209191-20-042125-index.htm
2018-06-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000121390018008022/0001213900-18-008022-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000121390019001901/0001213900-19-001901-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000121390020003214/0001213900-20-003214-index.htm
2019-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000139382519000090/0001393825-19-000090-index.htm
2019-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1469443/000153561019000022/0001535610-19-000022-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459018015415/0001564590-18-015415-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459018015580/0001564590-18-015580-index.htm
2018-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459018019212/0001564590-18-019212-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459018020491/0001564590-18-020491-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459018020562/0001564590-18-020562-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459018028025/0001564590-18-028025-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459018028112/0001564590-18-028112-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019002838/0001564590-19-002838-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019005220/0001564590-19-005220-index.htm
2019-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019009586/0001564590-19-009586-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1469443/000156459019010452/0001564590-19-010452-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1469443/000156459019012009/0001564590-19-012009-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1469443/000156459019013838/0001564590-19-013838-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019017218/0001564590-19-017218-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459019017310/0001564590-19-017310-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019020473/0001564590-19-020473-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019022034/0001564590-19-022034-index.htm
2019-06-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1469443/000156459019022276/0001564590-19-022276-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019022531/0001564590-19-022531-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019031308/0001564590-19-031308-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019032099/0001564590-19-032099-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459019032192/0001564590-19-032192-index.htm
2019-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019033353/0001564590-19-033353-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019034379/0001564590-19-034379-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019034733/0001564590-19-034733-index.htm
2019-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019036411/0001564590-19-036411-index.htm
2019-10-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019036506/0001564590-19-036506-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459019041018/0001564590-19-041018-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459019041132/0001564590-19-041132-index.htm
2019-12-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1469443/000156459019046289/0001564590-19-046289-index.htm
2020-01-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1469443/000156459020001677/0001564590-20-001677-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020012822/0001564590-20-012822-index.htm
2020-03-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1469443/000156459020012875/0001564590-20-012875-index.htm
2020-03-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1469443/000156459020013572/0001564590-20-013572-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1469443/000156459020017258/0001564590-20-017258-index.htm
2020-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1469443/000156459020017267/0001564590-20-017267-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020017687/0001564590-20-017687-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020025057/0001564590-20-025057-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459020025131/0001564590-20-025131-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020025284/0001564590-20-025284-index.htm
2020-05-18424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1469443/000156459020025980/0001564590-20-025980-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020025981/0001564590-20-025981-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020028230/0001564590-20-028230-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020031636/0001564590-20-031636-index.htm
2020-07-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000156459020031637/0001564590-20-031637-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020031777/0001564590-20-031777-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020032052/0001564590-20-032052-index.htm
2020-07-22S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000156459020033085/0001564590-20-033085-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1469443/000156459020040025/0001564590-20-040025-index.htm
2020-08-13S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1469443/000156459020040071/0001564590-20-040071-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1469443/000156459020040076/0001564590-20-040076-index.htm
2020-09-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1469443/000156459020042203/0001564590-20-042203-index.htm
2020-09-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1469443/000156459020043284/0001564590-20-043284-index.htm
2018-06-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1469443/999999999518001458/9999999995-18-001458-index.htm
2019-02-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1469443/999999999519000267/9999999995-19-000267-index.htm
2019-08-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1469443/999999999519001969/9999999995-19-001969-index.htm
2019-12-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1469443/999999999519002893/9999999995-19-002893-index.htm
2020-09-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1469443/999999999520002352/9999999995-20-002352-index.htm

Arcadia Biosciences, Inc (RKDA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arcadia Biosciences, Inc (RKDA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1219%
Institutional Ownership: 1117%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-26Matthew T PlavanChief Financial OfficerBuy1,000.008.338,330.001,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-09-10Matthew T PlavanChief Executive OfficerBuy1,000.006.526,520.5010,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/0001209191-19-049077-index.htm
2019-09-10Sarah ReiterChief Commercial OfficerBuy1,200.006.487,776.001,200.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119049070/0001209191-19-049070-index.htm
2019-09-23Matthew T PlavanChief Executive OfficerBuy2,000.005.2510,500.0012,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119050493/0001209191-19-050493-index.htm
2019-11-14Matthew T PlavanChief Executive OfficerBuy1,000.004.084,079.5013,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119056884/0001209191-19-056884-index.htm
2020-02-03Matthew T PlavanChief Executive OfficerBuy700.001.721,204.0013,700.00https://www.sec.gov/Archives/edgar/data/1469443/000120919120006282/0001209191-20-006282-index.htm
2019-09-10Kevin ComcowichDirectorBuy10,000.006.4964,900.0015,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119049067/0001209191-19-049067-index.htm
2020-02-03Pamela HaleyChief Financial OfficerBuy700.001.721,204.001,938.00https://www.sec.gov/Archives/edgar/data/1469443/000120919120006294/0001209191-20-006294-index.htm
2019-08-26Matthew T PlavanChief Financial OfficerBuy1,000.009.229,220.002,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-09-17Kevin ComcowichDirectorBuy5,000.005.8829,388.0020,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119049954/0001209191-19-049954-index.htm
2019-11-19Sarah ReiterChief Commercial OfficerBuy1,000.004.524,520.002,200.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119057375/0001209191-19-057375-index.htm
2019-08-27Matthew T PlavanChief Financial OfficerBuy1,000.009.329,320.003,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-12-23Sarah ReiterChief Commercial OfficerBuy900.005.955,355.003,100.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119061814/0001209191-19-061814-index.htm
2020-02-03Sarah ReiterChief Commercial OfficerBuy700.001.721,204.003,800.00https://www.sec.gov/Archives/edgar/data/1469443/000120919120006290/0001209191-20-006290-index.htm
2019-08-27Matthew T PlavanChief Financial OfficerBuy1,000.009.309,300.004,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-09-10Kevin ComcowichDirectorBuy5,000.006.4932,433.005,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119049067/0001209191-19-049067-index.htm
2019-08-27Matthew T PlavanChief Financial OfficerBuy1,000.008.958,950.005,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-08-27Matthew T PlavanChief Financial OfficerBuy2,000.008.9317,860.007,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-08-28Matthew T PlavanChief Financial OfficerBuy1,000.006.886,880.008,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/0001209191-19-047580-index.htm
2019-11-18Lilian Shackelford MurrayDirectorBuy5,000.004.2521,250.008,524.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119057084/0001209191-19-057084-index.htm
2019-09-10Matthew T PlavanChief Executive OfficerBuy1,000.006.496,493.009,000.00https://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/0001209191-19-049077-index.htm